Atlas Trials

Immunogenicity of H5N1 Vaccine Following H5N2

Clinical trial NCT02153671 · COMPLETED

Trial details

NCT number
NCT02153671
Sponsor
PATH
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Influenza Vaccine
Start date
2014-05-01
Primary completion
2014-09-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.